Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05470140 |
| Title | A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Wugen, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| Stanford Healthcare | Palo Alto | California | 94304 | United States | Details | |
| Norton Health Care | Louisville | Kentucky | 40299 | United States | Details | |
| University of Maryland | Baltimore | Maryland | 21201 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| Providence Portland Medical Center | Portland | Oregon | 97213 | United States | Details | |
| Peter MacCallum Cancer Center | Melbourne | Australia | Details | |||
| Royal Perth Hospital | Perth | Australia | Details | |||
| Royal Prince Alfred Hospital | Sydney | Australia | Details |